Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial
<strong>Purpose</strong> Malignant pleural mesothelioma (MPM) has a high symptom burden and poor survival. Evidence from other cancer types suggests some benefit in health-related quality of life (HRQoL) with early specialist palliative care (SPC) integrated with oncological services, bu...
Main Authors: | Brims, F, Gunatilake, S, Lawrie, I, Marshall, L, Fogg, C, Qi, C, Creech, L, Holtom, N, Killick, S, Yung, B, Cooper, D, Stadon, L, Cook, P, Fuller, E, Walther, J, Plunkett, C, Bates, A, Mackinlay, C, Tandon, A, Maskell, N, Forbes, K, Rahman, NM, Gerry, S, Chauhan, AJ |
---|---|
Format: | Journal article |
Published: |
BMJ Publishing Group
2019
|
Similar Items
-
A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma – ‘RESPECT-Meso’
by: Brims, F, et al.
Published: (2018) -
Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma
by: Fraser Brims
Published: (2021-08-01) -
The association between pleural fluid exposure and survival in pleural mesothelioma
by: Asciak, R, et al.
Published: (2021) -
Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
by: Alex Dipper, et al.
Published: (2021-06-01) -
BTS guideline for the investigation and management of malignant pleural mesothelioma
by: Woolhouse, I, et al.
Published: (2018)